Literature DB >> 15647007

Muscle endopin 1, a muscle intracellular serpin which strongly inhibits elastase: purification, characterization, cellular localization and tissue distribution.

Caroline Tassy1, Carlos H Herrera-Mendez, Miguel A Sentandreu, Laurent Aubry, Laure Brémaud, Patrick Pélissier, Didier Delourme, Michèle Brillard, Francis Gauthier, Hubert Levéziel, Ahmed Ouali.   

Abstract

In the present work, an endopin-like elastase inhibitor was purified for the first time from bovine muscle. A three-step chromatography procedure was developed including successively SP-Sepharose, Q-Sepharose and EMD-DEAE 650. This procedure provides about 300 microg of highly pure inhibitor from 500 g of bovine diaphragm muscle. The N-terminal sequence of the muscle elastase inhibitor, together with the sequence of a trypsin-generated peptide, showed 100% similarity with the cDNA deduced sequence of chromaffin cell endopin 1. Hence, the muscle inhibitor was designated muscle endopin 1 (mEndopin 1). mEndopin 1 had a molecular mass of 70 kDa, as assessed by both gel filtration and SDS/PAGE. According to the association rates determined, mEndopin 1 is a potent inhibitor of elastase (kass=2.41x10(7) M(-1).s(-1)) and trypsin (kass=3.92x10(6) M(-1).s(-1)), whereas plasmin (kass=1.78x10(3) M(-1).s(-1)) and chymotrypsin (kass=1.0x10(2) M(-1).s(-1)) were only moderately inhibited. By contrast, no inhibition was detected against several other selected serine proteinases, as well as against cysteine proteinases of the papain family. The cellular location of mEndopin in muscle tissue and its tissue distribution were investigated using a highly specific rabbit antiserum. The results obtained demonstrate an intracellular location and a wide distribution in bovine tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647007      PMCID: PMC1186716          DOI: 10.1042/BJ20041921

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

Review 1.  Cellular and molecular diversities of mammalian skeletal muscle fibers.

Authors:  D Pette; R S Staron
Journal:  Rev Physiol Biochem Pharmacol       Date:  1990       Impact factor: 5.545

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.

Authors:  C M Hekman; D J Loskutoff
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

5.  Purification and characterization of a low molecular weight cysteine proteinase inhibitor from bovine muscle.

Authors:  L Bige; A Ouali; C Valin
Journal:  Biochim Biophys Acta       Date:  1985-12-13

6.  Plasminogen activator: the major secreted neutral protease of cultured skeletal muscle cells.

Authors:  B W Festoff; M R Patterson; K Romstedt
Journal:  J Cell Physiol       Date:  1982-02       Impact factor: 6.384

7.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

8.  Reaction of azapeptides with human leukocyte elastase and porcine pancreatic elastase. New inhibitors and active site titrants.

Authors:  J C Powers; R Boone; D L Carroll; B F Gupton; C M Kam; N Nishino; M Sakamoto; P M Tuhy
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

9.  Thermal denaturation of antithrombin III. Stabilization by heparin and lyotropic anions.

Authors:  T F Busby; D H Atha; K C Ingham
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

10.  Characterization of sheep alpha-1-proteinase inhibitor. Important differences from the human protein.

Authors:  U Sinha; S Sinha; A Janoff
Journal:  Am Rev Respir Dis       Date:  1988-03
View more
  6 in total

1.  Mutagenesis of the bovSERPINA3-3 demonstrates the requirement of aspartate-371 for intermolecular interaction and formation of dimers.

Authors:  X Blanchet; A Péré-Brissaud; N Duprat; E Pinault; D Delourme; A Ouali; C Combet; A Maftah; P Pélissier; L Brémaud
Journal:  Protein Sci       Date:  2012-05-18       Impact factor: 6.725

2.  Multiple domains of endopin 2A for serpin cross-class inhibition of papain.

Authors:  Shin-Rong Hwang; Vivian Y H Hook
Journal:  Arch Biochem Biophys       Date:  2007-03-21       Impact factor: 4.013

3.  Expression of SERPINA3s in cattle: focus on bovSERPINA3-7 reveals specific involvement in skeletal muscle.

Authors:  Antoine Péré-Brissaud; Xavier Blanchet; Didier Delourme; Patrick Pélissier; Lionel Forestier; Arnaud Delavaud; Nathalie Duprat; Brigitte Picard; Abderrahman Maftah; Laure Brémaud
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

4.  Proteomic evaluation of sheep serum proteins.

Authors:  Elisabetta Chiaradia; Luca Avellini; Micaela Tartaglia; Alberto Gaiti; Ingo Just; Fausto Scoppetta; Zoltan Czentnar; Andreas Pich
Journal:  BMC Vet Res       Date:  2012-05-25       Impact factor: 2.741

5.  An original SERPINA3 gene cluster: elucidation of genomic organization and gene expression in the Bos taurus 21q24 region.

Authors:  Patrick Pelissier; Didier Delourme; Agnes Germot; Xavier Blanchet; Samira Becila; Abderrahman Maftah; Hubert Leveziel; Ahmed Ouali; Laure Bremaud
Journal:  BMC Genomics       Date:  2008-04-02       Impact factor: 3.969

6.  MSP22.8 is a protease inhibitor-like protein involved in shell mineralization in the edible mussel Mytilus galloprovincialis.

Authors:  Juan Calvo-Iglesias; Daniel Pérez-Estévez; África González-Fernández
Journal:  FEBS Open Bio       Date:  2017-09-17       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.